Latest Asx News

Acrow Ltd reported a robust 23% revenue increase in 1H FY26, driven by its expanding Industrial Access division, even as net profit fell 22% amid Queensland market softness. The company’s strategic investments and acquisitions position it well for future growth.

Bapcor Limited has postponed its half-year financial results release to no later than 27 February 2026 and is seeking an extension of its trading suspension, hinting at a potential capital raising.

Metro has announced a significant share consolidation, reducing its total shares on issue from nearly 984 million to approximately 24.6 million. The move aims to streamline the capital structure ahead of trading resumption in early March.

Eminence Minerals Limited has issued 2.7 million unquoted CEO performance rights as part of a new executive appointment, utilising its 15% placement capacity without shareholder approval.

Thorney Technologies reported a sharply reduced half-year profit amid challenging market conditions but extended its share buyback to support shareholder value.

Orcoda Limited has reported strong half-year FY26 results, showcasing significant growth in revenue, EBITDA, and recurring revenue as it advances its AI-powered transport ecosystem solutions.

SIV Capital Limited reported a 29.7% increase in its half-year loss to $172,763, with revenue down 41%, while its ASX suspension continues as it pursues a confidential transaction to regain listing status.

Eastern Gas Corporation Limited is set to raise $5.5 million through an IPO to fund drilling and flow testing at its Queensland gas exploration permits, aiming to prove commercial viability in the Surat and Cooper Basins.

Aspermont Limited has announced a significant security consolidation, reducing its ordinary shares on issue from nearly 2.91 billion to just over 11.6 million, aiming to streamline its capital structure and potentially enhance market liquidity.

TrivarX Limited reported a $1.26 million half-year loss as it completed the acquisition of Stabl-Im brain imaging IP and validated its mental health screening technology in veterans. The company raised $4.2 million to fund clinical development and expand its diagnostic portfolio.

333D Limited reported a 23% increase in revenue to $588,678 for the half-year ended December 2025, despite a 92% plunge in profit after tax to a $282,030 loss. The company boosted its cash reserves significantly and initiated a strategic Bitcoin investment.

QEM Limited confirms a $1.442 million capital raising via placement, addressing ASX queries on disclosure timing and compliance. The company clarifies board approvals and trading halt details, reinforcing its adherence to continuous disclosure obligations.